Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL1536 | 1.00 | NAPRT (0.69) | NAPRTTSHRTDP1NOTUMMEN1 | |
| Pyridine SCHEMBL27285374 | 0.96 | TSHR (0.64) | NAPRTTSHRTDP1NOTUMMEN1 | |
| Pyridine SCHEMBL28296779 | 0.86 | NAPRT (0.60) | NAPRTTSHRTDP1NOTUMMEN1 | |
| SCHEMBL34466311 | 0.83 | TSHR (1.00) | NAPRTTSHRTDP1NOTUMMEN1 | |
| Benzene SCHEMBL1261317 | 0.83 | TSHR (1.00) | NAPRTTSHRTDP1NOTUMMEN1 | |
| Pyridine SCHEMBL16 | 0.83 | — | — | |
| Pyridine SCHEMBL933604 | 0.83 | TSHR (1.00) | NAPRTTSHRTDP1NOTUMMEN1 | |
| SCHEMBL3052767 | 0.83 | TSHR (1.00) | NAPRTTSHRTDP1NOTUMMEN1 | |
| Pyridine SCHEMBL180431 | 0.83 | TSHR (1.00) | NAPRTTSHRTDP1NOTUMMEN1 | |
| Benzene SCHEMBL10751789 | 0.83 | TSHR (1.00) | NAPRTTSHRTDP1NOTUMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282806-A1 | CHEMICAL SYNTHESIS METHOD FOR DISACCHARIDE FRAGMENT OF VIBRIO VULNIFICUS BIOTYPE 2 SEROVAR A O-ANTIGEN | JIANGNAN UNIVERSITY (CN) | 2025-09-11 | — | — | US | claimed |
| WO-2025119223-A1 | METHOD FOR SYNTHESIZING AMANITIN AND DERIVATIVE THEREOF | 上海皓元生物医药科技有限公司 | 2025-06-12 | — | — | WO | claimed |
| WO-2025092728-A1 | INTERMEDIATE OF PNU-159682, AND PREPARATION METHOD THEREFOR | 上海皓元生物医药科技有限公司 | 2025-05-08 | — | — | WO | claimed |
| CN-119912476-A | Preparation method of PNU-159582 | 上海皓元生物医药科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-116462731-B | Cyclovirobuxine D diastereoisomers, diastereoisomers preparation method and application | 中国药科大学 | 2025-02-25 | — | — | CN | claimed |
| CN-115594739-B | Preparation method of dehydrodidemnin B compounds | 浙江珲达生物科技有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119391366-A | High-water-resistance soybean protein adhesive and preparation method and application thereof | 西南林业大学 | 2025-02-07 | — | — | CN | claimed |
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | WUYAN PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD (CN) | 2024-11-07 | — | — | US | claimed |
| CN-118812474-A | Water-soluble coumarin-based light-controlled latent incense body and preparation method and application thereof | 上海应用技术大学 | 2024-10-22 | — | — | CN | claimed |
| CN-118496286-A | Chemical synthesis method of vibrio vulnificus organism type 2A serotype O-antigen disaccharide fragment | 江南大学 | 2024-08-16 | — | — | CN | claimed |
| CN-116655462-A | Cyclooctatetraketone, preparation method and application thereof in preparation of macrocyclic polyamine compound | 上海凌凯医药科技有限公司 | 2023-08-29 | — | — | CN | claimed |
| US-11731962-B2 | LpxC inhibitor and methods of making | BLACKSMITH MEDICINES, INC. (US) | 2023-08-22 | — | — | US | claimed |
| CN-116462731-A | Cyclovirobuxine D diastereoisomer, preparation method and application | 中国药科大学 | 2023-07-21 | — | — | CN | claimed |
| CN-114436801-B | Cyclooctatetraketone, preparation method and application thereof in preparation of macrocyclic polyamine compound | 上海凌凯医药科技有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-115594739-A | Preparation method of dehydrodidemnin B compound | 浙江珲达生物科技有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| WO-2023274145-A1 | METHOD FOR PREPARING DEHYDRODIDEMNIN B COMPOUND | 浙江珲达生物科技有限公司 | 2023-01-05 | — | — | WO | claimed |
| CN-114736204-A | Preparation method of pexidaltinib structural analogue and application of pexidaltinib structural analogue in tumor resistance | 湖北工业大学 | 2022-07-12 | — | — | CN | claimed |
| CN-114436801-A | Cyclooctanedione, preparation method and application thereof in preparation of macrocyclic polyamine compounds | 上海凌凯医药科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| US-20220135613-A1 | METHOD FOR PREPARING DRUG TOXIN PNU-159682 FOR ANTIBODY DRUG CONJUGATE, AND INTERMEDIATES THEREIN | LEVENA BIOPHARMA CO LTD (CN) | 2022-05-05 | — | — | US | claimed |
| CN-114249726-A | Biphenyl compound, preparation method and application thereof | 深圳微芯生物科技股份有限公司 | 2022-03-29 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11731962-B2 | LpxC inhibitor and methods of making | LPXN, LCT, AGXT | NAPRT 209/4885TSHR 4822/4885TDP1 3906/4885 |
| US-20220135613-A1 | METHOD FOR PREPARING DRUG TOXIN PNU-159682 FOR ANTIBODY DRUG CONJUGATE, AND INTERMEDIATES THEREIN | ANTXR2, TNNT2, SLC47A2 | NAPRT 276/4885TSHR 775/4885TDP1 1674/4885 |
| US-20250282806-A1 | CHEMICAL SYNTHESIS METHOD FOR DISACCHARIDE FRAGMENT OF VIBRIO VULNIFICUS BIOTYPE 2 SEROVAR A O-ANTIGEN | OGA, DDOST, FUT6 | NAPRT 2203/4885TSHR 2596/4885TDP1 3772/4885 |
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | ANTXR2, AKR7A2, ACR | NAPRT 348/4885TSHR 322/4885TDP1 3635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.